Search

Your search keyword '"W. Froyman"' showing total 62 results

Search Constraints

Start Over You searched for: Author "W. Froyman" Remove constraint Author: "W. Froyman"
62 results on '"W. Froyman"'

Search Results

1. Imaging in gynecological disease (24): clinical and ultrasound characteristics of ovarian mature cystic teratomas

2. Hysteroscopic management of caesarean scar defects

3. E-book: Hematologie en hemostase – Uitgave 2023

4. Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation on IOTA 5 multicenter cohort

5. Tranexaminezuur in de gynaecologische en senologische heelkunde: een literatuuroverzicht

7. Uterine ultrasound and endometrial biopsy in tamoxifen users

8. Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer

9. Approaches for hysterectomy and implementation of robot-assisted surgery in benign gynaecological disease: A cost analysis study in a large university hospital.

10. Atypical epithelioid trophoblastic lesion presenting as pseudocyst from the niche in the cesarean scar: A case report and review of the literature.

11. Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.

12. Transvaginal ultrasound diagnosis of a rare entity: Premenopausal ovarian hyperthecosis.

13. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis.

14. Accessory cavitated uterine malformation (ACUM): A scoping review.

16. Variables Associated With Resolution and Persistence of Ovarian Cysts.

17. Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study.

18. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.

19. Multiclass risk models for ovarian malignancy: an illustration of prediction uncertainty due to the choice of algorithm.

20. Implementation of robot-assisted myomectomy in a large university hospital: a retrospective descriptive study.

21. O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee.

22. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.

23. Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort.

25. Imaging in gynecological disease (24): clinical and ultrasound characteristics of ovarian mature cystic teratomas.

27. Hysteroscopic management of caesarean scar defects.

28. Uterine hemangioma in pregnancy: A case report and review of the literature.

29. Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer.

30. Imaging in gynecological disease (23): clinical and ultrasound characteristics of ovarian carcinosarcoma.

32. Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer.

33. Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et al.

34. A Prospective International Lung Ultrasound Analysis Study in Tertiary Maternity Wards During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.

35. Ultrasound evaluation of ovarian masses and assessment of the extension of ovarian malignancy.

36. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

37. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors.

38. Imaging in gynecological disease (22): clinical and ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.

39. Safety and efficiency of performing transvaginal ultrasound-guided tru-cut biopsy for pelvic masses.

41. Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors.

42. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).

43. Uterine ultrasound and endometrial biopsy in tamoxifen users.

44. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.

45. Methods of Assessing Ovarian Masses: International Ovarian Tumor Analysis Approach.

46. Advanced Doppler imaging and trucut biopsy of a late-stage cervical lymphoma.

47. Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors.

48. Intra- and Inter-Rater Agreement Describing Myometrial Lesions Using Morphologic Uterus Sonographic Assessment: A Pilot Study.

49. Juvenile cystic adenomyosis: A case report and review of the literature.

50. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.

Catalog

Books, media, physical & digital resources